The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Relationship Between Patient Medication Adherence and Subsequent Clinical Inertia in Type 2 Diabetes Glycemic Management
Abstract
OBJECTIVE—Clinical inertia has been identified as a critical barrier to glycemic control in type 2 diabetes. We assessed the relationship between patients' initial medication adherence and subsequent regimen intensification among patients with persistently elevated A1C levels. RESEARCH DESIGN AND METHODS—We analyzed an inception cohort of 2,065 insured patients with type 2 diabetes who were newly started on hypoglycemic therapy and were followed for at least 3 years between 1992 and 2001. Medication adherence was assessed by taking the ratio of medication days dispensed (from pharmacy records) to medication days prescribed (as documented in the medical record) for the first prescribed hypoglycemic drug. Adherence was measured for the period between medication initiation and the next elevated A1C result measured at least 3 months later; intensification was defined as a dose increase or the addition of a second hypoglycemic agent. RESULTS—Patients were aged (mean ± SD) 55.4 ± 12.2 years; 53% were men, and 19% were black. Baseline medication adherence was 79.8 ± 19.3%. Patients in the lowest quartile of adherence were significantly less likely to have their regimens increased within 12 months of their first elevated A1C compared with patients in the highest quartile (27 vs. 37%, respectively, with increased regimens if A1C is elevated, P < 0.001). In multivariate models adjusting for patient demographic and treatment factors, patients in the highest adherence quartile had 53% greater odds of medication intensification after an elevated A1C (95% CI 1.11–1.93, P = 0.01). CONCLUSIONS—Among insured diabetic patients with elevated A1C, level of medication adherence predicted subsequent medication intensification. Poor patient self-management behavior increases therapeutic clinical inertia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Phillips, L. S., Branch, W. T., Cook, C. B., Doyle, J. P., El-Kebbi, I. M., Gallina, D. L., Miller, C. D., Ziemer, D. C., & Barnes, C. S. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-9-200111060-00012 · Cited by 1,370
Buchanan, T. A., Xiang, A. H., Peters, R. K., Kjos, S. L., Marroquin, A., Goico, J., Ochoa, C., Tan, S., Berkowitz, K., Hodis, H. N., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.9.2796 · Cited by 1,339
Quality of Diabetes Care in U.S. Academic Medical Centers
Grant, R. W., Buse, J. B., Meigs, J. B., & for the University HealthSystem Consortium (UHC) Diabetes Benchmarking Project Team (2005) · Diabetes Care · doi:10.2337/diacare.28.2.337 · Cited by 311
Self-citationPhillips, L. S., Ziemer, D. C., Doyle, J. P., Barnes, C. S., Kolm, P., Branch, W. T., Caudle, J. M., Cook, C. B., Dunbar, V. G., El-Kebbi, I. M., et al. (2005) · Diabetes Care · doi:10.2337/diacare.28.10.2352 · Cited by 108
Cited by
Shippee, N. D., Shah, N. D., May, C. R., Mair, F. S., & Montori, V. M. (2012) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2012.05.005 · Cited by 728
Clinical Inertia in People With Type 2 Diabetes
Khunti, K., Wolden, M. L., Thorsted, B. L., Andersen, M., & Davies, M. J. (2013) · Diabetes Care · doi:10.2337/dc13-0331 · Cited by 613
Kooy, A., de Jager, J., Lehert, P., Bets, D., Wulffelé, M. G., Donker, A. J. M., & Stehouwer, C. D. A. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.20 · Cited by 440
A Review of Diabetes Treatment Adherence and the Association with Clinical and Economic Outcomes
Asche, C., LaFleur, J., & Conner, C. (2011) · Clinical Therapeutics · doi:10.1016/j.clinthera.2011.01.019 · Cited by 420
Khunti, K., Gomes, M. B., Pocock, S., Shestakova, M. V., Pintat, S., Fenici, P., Hammar, N., & Medina, J. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13088 · Cited by 367
Medication Taking and Diabetes
Odegard, P. S., & Capoccia, K. (2007) · The Diabetes Educator · doi:10.1177/0145721707308407 · Cited by 273
Patient adherence to medication requirements for therapy of type 2 diabetes
Bailey, C. J., & Kodack, M. (2011) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2010.02544.x · Cited by 255
Parchman, M. L., Zeber, J. E., & Palmer, R. F. (2010) · The Annals of Family Medicine · doi:10.1370/afm.1161 · Cited by 254
Schmittdiel, J. A., Uratsu, C. S., Karter, A. J., Heisler, M., Subramanian, U., Mangione, C. M., & Selby, J. V. (2008) · Journal of General Internal Medicine · doi:10.1007/s11606-008-0554-8 · Cited by 239
Longitudinal effects of medication nonadherence on glycemic control
Egede, L. E., Gebregziabher, M., Echols, C., & Lynch, C. P. (2014) · Annals of Pharmacotherapy · doi:10.1177/1060028014526362 · Cited by 146
Andreozzi, F., Candido, R., Corrao, S., Fornengo, R., Giancaterini, A., Ponzani, P., Ponziani, M. C., Tuccinardi, F., & Mannino, D. (2020) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-020-00559-7 · Cited by 128
Fairall, L. R., Folb, N., Timmerman, V., Lombard, C., Steyn, K., Bachmann, M. O., Bateman, E. D., Lund, C., Cornick, R., Faris, G., et al. (2016) · PLoS Medicine · doi:10.1371/journal.pmed.1002178 · Cited by 99
Clifford, S., Perez-Nieves, M., Skalicky, A. M., Reaney, M., & Coyne, K. S. (2014) · Current Medical Research and Opinion · doi:10.1185/03007995.2014.884491 · Cited by 99
Interactive Behavior Change Technology to Support Diabetes Self-Management
Piette, J. D. (2007) · Diabetes Care · doi:10.2337/dc07-1046 · Cited by 90
From victim to ally: the kidney as an emerging target for the treatment of diabetes mellitus
Bays, H. (2009) · Current Medical Research and Opinion · doi:10.1185/03007990802710422 · Cited by 83
Saad, A. M. J., Younes, Z. M. H., Ahmed, H., Brown, J. A., Al Owesie, R. M., & Hassoun, A. A. K. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.12.014 · Cited by 78
Mata‐Cases, M., Franch‐Nadal, J., Real, J., Gratacòs, M., López‐Simarro, F., Khunti, K., & Mauricio, D. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13045 · Cited by 72
Clinical inertia in the treatment of hyperglycemia in type 2 diabetes patients in primary care
Mata-Cases, M., Benito-Badorrey, B., Roura-Olmeda, P., Franch-Nadal, J., Pepió-Vilaubí, J. M., Saez, M., Coll-de-Tuero, G., & on behalf of the GEDAPS (Primary Care Group for the study of Diabetes) of the Catalonian Society of Family and Community Medicine (2013) · Current Medical Research and Opinion · doi:10.1185/03007995.2013.833089 · Cited by 70
Skinner, J. S., Poe, B., Hopper, R., Boyer, A., & Wilkins, C. H. (2015) · The Diabetes Educator · doi:10.1177/0145721715587563 · Cited by 52
Family Physician Clinical Inertia in Glycemic Control among Patients with Type 2 Diabetes
Kranjčević, K. (2015) · Medical Science Monitor · doi:10.12659/msm.892248 · Cited by 39
Gerber, B. S., Rapacki, L., Castillo, A., Tilton, J., Touchette, D. R., Mihailescu, D., Berbaum, M. L., & Sharp, L. K. (2012) · BMC Public Health · doi:10.1186/1471-2458-12-891 · Cited by 33
Maegawa, H., Ishigaki, Y., Langer, J., Saotome‐Nakamura, A., Andersen, M., & the Japan Diabetes Clinical Data Management (JDDM) Study Group (2021) · Journal of Diabetes Investigation · doi:10.1111/jdi.13352 · Cited by 18
Therapeutic inertia amongst general practitioners with interest in diabetes
Seidu, S., Than, T., Kar, D., Lamba, A., Brown, P., Zafar, A., Hussain, R., Amjad, A., Capehorn, M., Martin, E., et al. (2018) · Primary Care Diabetes · doi:10.1016/j.pcd.2017.09.001 · Cited by 17
Sharp, L. K., Biggers, A., Perez, R., Henkins, J., Tilton, J., & Gerber, B. S. (2021) · JMIR Research Protocols · doi:10.2196/17170 · Cited by 11
Clinical inertia among patients with type 2 diabetes mellitus treated with DPP-4i and/or SGLT-2i
Lanzinger, S., Schmid, S. M., Welp, R., Zimmermann, A., Fasching, P., Wagner, S., & Holl, R. W. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.10.011 · Cited by 4
Rathod, L., Khan, S., Shubham, S., Bisne, N., Singh, S., Kumar, M., Tiwari, R., & Sarma, D. K. (2024) · Cureus · doi:10.7759/cureus.69956 · Cited by 1
Metadata
- Authors
- Grant, R., Adams, A. S., Trinacty, C. M., Zhang, F., Kleinman, K., Soumerai, S. B., Meigs, J. B., & Ross-Degnan, D.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2007-04-01
- Volume
- 30
- Issue
- 4
- Pages
- 807-812
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2137808916
- Cited by
- 218
- References
- 4
- FWCI
- 11.72
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.